Molecular Mechanisms of Cardiac Remodeling and Regeneration in Physical Exercise
Overview
Biophysics
Cell Biology
Molecular Biology
Affiliations
Regular physical activity with aerobic and muscle-strengthening training protects against the occurrence and progression of cardiovascular disease and can improve cardiac function in heart failure patients. In the past decade significant advances have been made in identifying mechanisms of cardiomyocyte re-programming and renewal including an enhanced exercise-induced proliferational capacity of cardiomyocytes and its progenitor cells. Various intracellular mechanisms mediating these positive effects on cardiac function have been found in animal models of exercise and will be highlighted in this review. 1) activation of extracellular and intracellular signaling pathways including phosphatidylinositol 3 phosphate kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR), EGFR/JNK/SP-1, nitric oxide (NO)-signaling, and extracellular vesicles; 2) gene expression modulation via microRNAs (miR), in particular via miR-17-3p and miR-222; and 3) modulation of cardiac cellular metabolism and mitochondrial adaption. Understanding the cellular mechanisms, which generate an exercise-induced cardioprotective cellular phenotype with physiological hypertrophy and enhanced proliferational capacity may give rise to novel therapeutic targets. These may open up innovative strategies to preserve cardiac function after myocardial injury as well as in aged cardiac tissue.
The role of long non-coding RNAs in cardiovascular diseases: A comprehensive review.
Xie X, Huang M, Ma S, Xin Q, Wang Y, Hu L Noncoding RNA Res. 2025; 11:158-187.
PMID: 39896344 PMC: 11783329. DOI: 10.1016/j.ncrna.2024.12.009.
Suematsu Y, Morita H, Abe M, Uehara Y, Koyoshi R, Fujimi K Hypertens Res. 2024; 48(2):720-732.
PMID: 39487318 DOI: 10.1038/s41440-024-01974-3.
Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases.
Dragoi C, Diaconu C, Nicolae A, Dumitrescu I Antioxidants (Basel). 2024; 13(10).
PMID: 39456418 PMC: 11504313. DOI: 10.3390/antiox13101163.
Vitamin D-Parathyroid Hormone-Fibroblast Growth Factor 23 Axis and Cardiac Remodeling.
Deng C, Wu Y Am J Cardiovasc Drugs. 2024; 25(1):25-36.
PMID: 39392562 DOI: 10.1007/s40256-024-00688-8.
Novel Approaches to Program Cells to Differentiate into Cardiomyocytes in Myocardial Regeneration.
Bonavida V, Ghassemi K, Ung G, Inouye K, Thankam F, Agrawal D Rev Cardiovasc Med. 2024; 23(12):392.
PMID: 39076655 PMC: 11270456. DOI: 10.31083/j.rcm2312392.